BiotechTube

YHD1119 + Lyrica

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Peripheral Nueropathy Pain

Conditions

Peripheral Nueropathy Pain

Trial Timeline

Jun 1, 2016 → Nov 1, 2016

NCT ID
NCT02783183

About YHD1119 + Lyrica

YHD1119 + Lyrica is a phase 1 stage product being developed by Yuhan for Peripheral Nueropathy Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02783183. Target conditions include Peripheral Nueropathy Pain.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (3)

NCT IDPhaseStatus
NCT02985216Phase 3Completed
NCT02783183Phase 1Completed
NCT02783638Phase 1Completed

Competing Products

20 competing products in Peripheral Nueropathy Pain

See all competitors
ProductCompanyStageHype Score
SON-080Sonnet BioTherapeuticsPhase 1/2
36
LY3857210 + PlaceboEli LillyPhase 2
52
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgYuhanApproved
85
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidYuhanApproved
85
YHD1119 + LyricaYuhanPhase 1
33
YHD1119 + LyricaYuhanPhase 3
77
YHD1119 300mg + YHD1119 300mgYuhanPhase 1
33
DS-5565 tablet + pregabalin capsule + Placebo tablet + placebo capsuleDaiichi SankyoPhase 2
52
edoxaban + Clopidogrel + AspirinDaiichi SankyoPhase 2
52
DS-5565 + placeboDaiichi SankyoPhase 3
77
Mirogabalin + PlaceboDaiichi SankyoPhase 3
77
DS-5565Daiichi SankyoPhase 3
77
Valemetostat TosylateDaiichi SankyoPhase 2
52
ASP3662 + pregabalin + ASP3662 placebo + pregabalin placeboAstellas PharmaPhase 2
52
QutenzaAstellas PharmaPre-clinical
23
QUTENZA + Lidocaine + TramadolAstellas PharmaApproved
85
Qutenza exposureAstellas PharmaPre-clinical
23
QUTENZAAstellas PharmaPhase 3
77
Qutenza + PregabalinAstellas PharmaApproved
85
Capsaicin 8% + PlaceboAstellas PharmaPhase 3
77

Other Products from Yuhan

generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)Approved
85
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgApproved
85
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidApproved
85
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgApproved
85
Atorvastatin 20mg loading + Atorvastatin 80mg loadingApproved
85